Skip to Main Content

Charalambos (Babis) Andreadis


Cancer therapy researcher and food aficionado

Dr. Charalambos (Babis) Andreadis specializes in bone marrow transplantation for adults and in treating Hodgkin's and non-Hodgkin's lymphoma, leukemia and multiple myeloma. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. His research, published widely in scientific journals, examines genetic and other factors that affect how patients respond to therapy, including degrees of drug toxicity. He also studies patient outcomes in these disorders.

Andreadis earned his medical degree at Columbia University's Vagelos College of Physicians and Surgeons, and was elected to the Alpha Omega Alpha Honor Medical Society in 1998. He completed a residency at New York-Presbyterian Hospital and a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, where he joined the faculty in 2004. He also earned a master's degree in clinical epidemiology at the University of Pennsylvania, focusing on pharmacogenetics, the study of how genes impact an individual's response to medications.

  • Education

    Columbia University College of Physicians and Surgeons, 1998

  • Residencies

    Columbia Presbyterian Medical Center, Internal Medicine, 2001

  • Fellowships

    University of Pennsylvania, Hematology-Oncology, 2004

  • Academic Title


  • Languages



I aspire to guiding patients through diagnosis, treatment and recovery with a scientifically rigorous and highly personalized approach.

Where I see patients (1)

    My reviews


    Overall Experience
    277 Ratings
    Explained things in a way that was easy to understand
    273 Ratings
    Did the doctor pay attention to your concerns
    273 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    272 Ratings
    Knew the important information about your medical history
    274 Ratings
    The provider showed respect for what you had to say
    275 Ratings
    The provider spent enough time with me
    274 Ratings
    Decorative Caduceus

    Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell Therapy

    Will calculate the uniformly minimum-variance unbiased estimator, p-value and 95% confidence interval (CI) for the response rates.